226 related articles for article (PubMed ID: 28374470)
41. Aggressive fresh frozen plasma (FFP) with massive blood transfusion in the absence of acute traumatic coagulopathy.
Mitra B; Cameron PA; Gruen RL
Injury; 2012 Jan; 43(1):33-7. PubMed ID: 22071285
[TBL] [Abstract][Full Text] [Related]
42. Use of Plasma for Acquired Coagulation Factor Deficiencies in Critical Care.
Shah A; McKechnie S; Stanworth S
Semin Thromb Hemost; 2016 Mar; 42(2):95-101. PubMed ID: 26716502
[TBL] [Abstract][Full Text] [Related]
43. The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation: A randomised controlled study.
Bonnet A; Gilquin N; Steer N; Gazon M; Quattrone D; Pradat P; Maynard M; Mabrut JY; Aubrun F
Eur J Anaesthesiol; 2019 Nov; 36(11):825-833. PubMed ID: 31567574
[TBL] [Abstract][Full Text] [Related]
44. Results of rotational thromboelastometry, coagulation activation markers and thrombin generation assays in orthopedic patients during thromboprophylaxis with rivaroxaban and enoxaparin: a prospective cohort study.
Oswald E; Velik-Salchner C; Innerhofer P; Tauber H; Auckenthaler T; Ulmer H; Streif W
Blood Coagul Fibrinolysis; 2015 Mar; 26(2):136-44. PubMed ID: 25396759
[TBL] [Abstract][Full Text] [Related]
45. Elective fresh frozen plasma in the critically ill: what is the evidence?
Verghese SG
Crit Care Resusc; 2008 Sep; 10(3):264-8. PubMed ID: 18798728
[TBL] [Abstract][Full Text] [Related]
46. Perioperative Thromboelastometry for Adult Living Donor Liver Transplant Recipients with a Tendency to Hypercoagulability: A Prospective Observational Cohort Study.
Kamel Y; Hassanin A; Ahmed AR; Gad E; Afifi M; Khalil M; Görlinger K; Yassen K
Transfus Med Hemother; 2018 Nov; 45(6):404-412. PubMed ID: 30574058
[TBL] [Abstract][Full Text] [Related]
47. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components.
Gajic O; Yilmaz M; Iscimen R; Kor DJ; Winters JL; Moore SB; Afessa B
Crit Care Med; 2007 Jul; 35(7):1645-8. PubMed ID: 17522583
[TBL] [Abstract][Full Text] [Related]
48. Clinical efficacy of riboflavin and ultraviolet light inactivated fresh frozen plasma evaluated with INR-quantification.
Stanojkovic Z; Balint B; Antic A; Todorovic M; Ostojic G; Pavlovic M
Transfus Apher Sci; 2012 Aug; 47(1):33-7. PubMed ID: 22465578
[TBL] [Abstract][Full Text] [Related]
49. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
[TBL] [Abstract][Full Text] [Related]
50. Impact of fresh frozen plasma transfusion on mortality in extracorporeal membrane oxygenation.
Luo Z; Qin L; Xu S; Yang X; Peng Z; Huang C
Perfusion; 2024 Mar; 39(2):294-303. PubMed ID: 36305199
[TBL] [Abstract][Full Text] [Related]
51. Fresh Frozen Plasma Use in a Neonatal Unit in South Africa.
Raban MS; Harrison MC
J Trop Pediatr; 2015 Aug; 61(4):266-71. PubMed ID: 25920397
[TBL] [Abstract][Full Text] [Related]
52. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery.
Ogawa S; Szlam F; Chen EP; Nishimura T; Kim H; Roback JD; Levy JH; Tanaka KA
Transfusion; 2012 Jan; 52(1):14-22. PubMed ID: 21756263
[TBL] [Abstract][Full Text] [Related]
53. Controversies in the use of fresh frozen plasma in critically ill small animal patients.
Beer KS; Silverstein DC
J Vet Emerg Crit Care (San Antonio); 2015; 25(1):101-6. PubMed ID: 25603692
[TBL] [Abstract][Full Text] [Related]
54. Coagulation management with factor concentrates in liver transplantation: a single-center experience.
Kirchner C; Dirkmann D; Treckmann JW; Paul A; Hartmann M; Saner FH; Görlinger K
Transfusion; 2014 Oct; 54(10 Pt 2):2760-8. PubMed ID: 24827116
[TBL] [Abstract][Full Text] [Related]
55. A national clinical scenario-based survey of clinicians' attitudes towards fresh frozen plasma transfusion for critically ill patients.
Watson DM; Stanworth SJ; Wyncoll D; McAuley DF; Perkins GD; Young D; Biggin KJ; Walsh TS
Transfus Med; 2011 Apr; 21(2):124-9. PubMed ID: 21062383
[TBL] [Abstract][Full Text] [Related]
56. Fresh frozen plasma dosing for warfarin reversal: a practical formula.
Rashidi A; Tahhan HR
Mayo Clin Proc; 2013 Mar; 88(3):244-50. PubMed ID: 23489450
[TBL] [Abstract][Full Text] [Related]
57. Effect of plasma component transfusion on conventional coagulation screening tests.
Raturi M; Shastry S; Murugesan M; Baliga PB; Chakravarthy K
Asian J Transfus Sci; 2018; 12(1):57-61. PubMed ID: 29563677
[TBL] [Abstract][Full Text] [Related]
58. Fresh-frozen plasma transfusion did not reduce 30-day mortality in patients undergoing cardiopulmonary bypass cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study.
Doussau A; Perez P; Puntous M; Calderon J; Jeanne M; Germain C; Rozec B; Rondeau V; Chêne G; Ouattara A; Janvier G;
Transfusion; 2014 Apr; 54(4):1114-24. PubMed ID: 24117772
[TBL] [Abstract][Full Text] [Related]
59. Fresh frozen plasma and recombinant factor VIIa use in neonates.
Puetz J; Darling G; McCormick KA; Wofford JD
J Pediatr Hematol Oncol; 2009 Dec; 31(12):901-6. PubMed ID: 19956022
[TBL] [Abstract][Full Text] [Related]
60. [Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy].
Lepri D; Capuzzo E; Mattioli AV; Dall'Oglio D; Sgarioto V; Terenziani I; Caramaschi G; Manzato F; Franchini M
Recenti Prog Med; 2013 Mar; 104(3):106-11. PubMed ID: 23548954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]